Cipher Pharmaceuticals Inc. logo

Cipher Pharmaceuticals Inc. (CPHRF)

Market Closed
12 Dec, 20:00
OTC GREY OTC GREY
$
10. 20
-0.05
-0.49%
$
271.99M Market Cap
- P/E Ratio
0% Div Yield
500 Volume
- Eps
$ 10.25
Previous Close
Day Range
10.2 10.2
Year Range
6.63 12.5
Want to track CPHRF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 89 days
Cipher Pharmaceuticals Inc. (CPHRF) Q2 2025 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (CPHRF) Q2 2025 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Bryan Jacobs - President Craig J. Mull - Interim CEO & Chairman of the Board Ryan Mailling - Chief Financial Officer Conference Call Participants Andre Uddin - Research Capital Corporation, Research Division Douglas W.

Seekingalpha | 4 months ago
Cipher Pharmaceuticals Inc. (CPHRF) Q1 2025 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (CPHRF) Q1 2025 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Ryan Mailling - Chief Financial Officer Conference Call Participants Andre Uddin - Research Capital Justin Keywood - Stifel Doug Loe - Leede Financials Operator Good morning, ladies and gentlemen. Thank you for standing by.

Seekingalpha | 7 months ago
Cipher Pharmaceuticals Inc. (CPHRF) Q4 2024 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (CPHRF) Q4 2024 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ET Company Participants Craig Mull - Interim CEO Ryan Mailling – CFO Bryan Jacobs - President of U.S. Operations Conference Call Participants Andre Uddin - Research Capital Justin Keywood – Stifel Operator Good morning, ladies and gentlemen. Thank you for standing by.

Seekingalpha | 8 months ago